Cavutilide

CAS No. 1276186-19-6

Cavutilide( —— )

Catalog No. M35602 CAS No. 1276186-19-6

Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
25MG 1444 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cavutilide
  • Note
    Research use only, not for human use.
  • Brief Description
    Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
  • Description
    Cavutilide, benzamide, is used as an antiarrhythmic, antiarythmique.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1276186-19-6
  • Formula Weight
    399.458
  • Molecular Formula
    C22H26FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCN1CCC(CC(c(cc2)ccc2F)NC(c(cc2)ccc2[N+]([O-])=O)=O)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. WHO Drug Information, Vol. 36, No. 2, 2022.
molnova catalog
related products
  • (E)-AG 556

    AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.

  • Gefitinib hydrochlor...

    A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM.

  • Vandetanib

    Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.